September 10th 2025
Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.
)
July 22nd 2025
Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of high-quality antigens and biologicals, for research and manufacturing of diagnostic products.
)
January 11th 2021
From the outset of the COVID-19 outbreak, testing for SARS-CoV-2 has been a priority. Initially just having a test for COVID-19 was a scientific success, enabled by the publication of the first viral genomic sequence in January 2020. Here we highlight some of the key testing events that have taken place, and their outcomes.
)
August 5th 2020
Two types of tests for SARS-CoV-2 currently predominate. The first are molecular tests, based on PCR technology, that detect the presence of viral nucleic acid and therefore indicate a current infection. The second are serology tests.
)
May 20th 2019
Irregular antibodies are antibodies found in the blood of transfusion donors that have the potential to cause hemolysis of the recipient blood. Screening using an indirect Coombs Test should be performed to ensure that the donor blood is compatible with the recipient.
)